Overview

The DIA SAFETY360° Conference on Clinical & Post-Market Safety 2026 brings together regulators, industry, and academia to advance an integrated approach to drug, device, and cosmetic safety – from clinical development to real-world use. The conference offers a neutral and comprehensive platform to examine healthcare product safety across the full lifecycle, addressing evolving expectations in clinical safety, pharmacovigilance, materiovigilance, and cosmetovigilance. Through expert-led discussions, the programme highlights advances in safety science, regulatory convergence, digital innovation, and real-world evidence to strengthen patient and consumer protection.

Featured

Want to learn more about SAFETY360°: DIA Conference on Clinical & Post-Market Safety? You've come to the right site!

Exhibits

Learn more

Exhibits

Learn more

Who should attend?

This conference is designed for professionals involved in the development, regulation, and oversight of safety of healthcare products, including:

Regulators and policy makers in drug, medical device, and cosmetic safety
Clinical research, clinical safety, and pharmacovigilance professionals
Materiovigilance and cosmetovigilance practitioners
Regulatory affairs, quality, and compliance leaders
Medical affairs, risk management, and safety scientists
Data, digital, and real-world evidence professionals supporting safety functions
Academia, researchers, and subject-matter experts in safety science

Learning objectives

At the end of this conference, participants will be able to:
• Understand evolving regulatory expectations across clinical safety, pharmacovigilance, materiovigilance, and cosmetovigilance
• Apply a lifecycle-based approach to safety for drugs, medical devices, and cosmetics
• Leverage real-world evidence and digital tools to support safety decision-making
• Anticipate emerging trends in safety science to strengthen patient and consumer protection.

Program Committee

Vivek Ahuja Program Chair-PV Track, Executive Vice President, Pharmacovigilance
EVERSANA, India
Gurpreet Singh Chief Business Officer, Pharmacovigilance & Clinical
Pivot Path, United Kingdom
Nitu Sinha Vice President & Global Head
Mankind Pharma Ltd, India
J Vijay Venkatraman Managing Director and CEO
Oviya Medsafe Pvt Ltd, India
Avinash Kakade Sr Vice President Global Head of Pharmacovigilance
Dr Reddy's Laboratories, India
Kamal Shahani Managing Director
Tenet Health Edutech Pvt. Ltd. (Cliniminds, CRQA, Thinki & Mediminds), India
Kausik Maiti, MD Vice President, Patient Safety Medical Sciences
Parexel International , India
Sumati Randeo MD & Founder
QR Synergies, India
Sanjeev Sachdeva, MCA Global Head - Advisory and Business Process Services, Life Sciences
Tata Consultancy Services, India
Retesh Bhumbak, MD World Wide Patient Safety Site Head- Hyderabad
Bristol Myers Squibb, India
Ashok Kumar Swain General Manager, India
DIA, India